中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

已选(0)清除 条数/页：   排序方式：
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping;  Chen, Huafei;  Xu, Chunwei;  Zhang, Xiaoyan;  Yuan, Hongling;  Lou, Guangyuan;  Shao, Lan;  Zhang, Gu;  Song, Zhengbo
收藏  |  浏览/下载：46/0  |  提交时间：2022/05/16
BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy  
Utilization of genetic biomarkers testing and its associated factors in advanced colorectal cancer patients in China: a nationwide multicenter clinical epidemiological study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2022
作者:  Zhang, Xi;  Lian, Xue-Mei;  Gu, Xiao-Fen;  Liu, Yin;  Feng, Chang-Yan;  Li, Li;  Xu, Hui-Fang;  Du, Jing-Chang;  Zhao, Yu-Qian;  Ma, Li;  Liu, Yun-Yong;  Huang, Juan-Xiu;  Cao, Ji;  Wang, Xiao-Hui;  Du, Ling-Bin;  Duan, Shuang-Xia;  Wang, Wen-Jun;  Fan, Yan-Ping;  Yu, Yan-Qin;  Zhang, Shao-Kai;  Shi, Ji-Hai;  Qiao, You-Lin
收藏  |  浏览/下载：52/0  |  提交时间：2022/05/16
Colorectal cancer (CRC)  biomarker  RAS  BRAF  microsatellite instability (MSI)  
Dysembryoplastic neuroepithelial tumor-like pilocytic astrocytoma: A case report 期刊论文
MEDICINE, 2018, 卷号: 97, 期号: 20, 页码: 4
作者:  Liao, Jia-Ming;  Wang, Wei;  Xie, Jing;  Wu, Hai-Bo
浏览  |  Adobe PDF(530Kb)  |  收藏  |  浏览/下载：64/26  |  提交时间：2019/08/26
dysembryoplastic neuroepithelial tumor  fluorescence in situ hybridisation  KIAA1549-BRAF fusion gene  pilocytic astrocytoma  
Novel anti-melanoma treatment: focus on immunotherapy 期刊论文
CHINESE JOURNAL OF CANCER, 2014, 卷号: 33
作者:  Hao MengZe;  Zhou WenYa;  Du XiaoLing;  Chen KeXin;  Wang GuoWen;  Yang Yun;  Yang JiLong
收藏  |  浏览/下载：44/0  |  提交时间：2020/12/28
HIGH-DOSE INTERLEUKIN-2  EMD 521873 SELECTIKINE  PHASE-III TRIAL  METASTATIC MELANOMA  MEK INHIBITION  CLINICAL-TRIAL  BRAF  IPILIMUMAB  CANCER  VACCINATION  Melanoma  immunotherapy  tumor vaccine  cytokine  CTLA-4  PD-1